The Global In-vitro Diagnostics market emerge the market growth owing to rising chronic diseases and development in advance technology
The Global In-vitro Diagnostics market will spur CAGR in the forecast period from 2020-2027. With the changing lifestyle of people, there are higher requirements for disease risk prediction, health management, chronic disease management, etc. The In-vitro diagnostic market has vast room for development, especially in regions and countries with underdeveloped medical standards.
Among the types of IVD products, the localization rate of midstream products of molecular diagnosis is relatively high, and the downstream diagnosis service market is increasing. Also, information technology, big data, cloud computing, and the Internet have gradually strengthened interaction and integration with various industries and are also subverting the development model of multiple sectors.
Therefore, the traditional business model of the IVD industry is to obtain profits by selling instruments and reagent products, providing medical testing services and laboratory solutions, and the future development of the IVD industry will also usher in significant changes.
Product Overview in the Global In-vitro Diagnostics Market
Based on the product, the global In-Vitro Diagnostics market segmented into Reagents, Instruments, and Software & Services. The instrument segment has captured the highest market value in the comprehensive In-vitro diagnostics market in the forecast period from 2020-2027. It is mainly owing to the emerging need for early diagnosis of infectious diseases. Moreover, reagents will bolster the market demand for the global In-vitro diagnostics market. It is mainly owing to rising technology and convenient non-invasive device and home care kits.
Technique Overview in the Global In-vitro Diagnostics Market
Based on the technique, the global In-Vitro Diagnostics market classified into Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques. The Immunodiagnostics segment has dominated the market share of the global In-vitro diagnostics market. With the continuous development and progress of technology, the low-end immunodiagnosis field has achieved good localization results. However, the high-end immunodiagnosis field is still dominated by foreign giants and fuels the market demand for IVD in the future as well.
Application Overview in the Global In-vitro Diagnostics Market
Based on the application, the global In-Vitro Diagnostics market aggregated into Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications. Infectious diseases have the largest share in the in-vitro diagnostic market. It is mainly owing to the emerging conditions and outbreak of contagious diseases, causing epidemic fueled the market demand of IVD in the future as well.
End-use Overview in the Global In-vitro Diagnostics Market
Based on End-use, the global In-Vitro Diagnostics market classified into Standalone laboratories, Hospitals, Academic & Medical Schools, Point of Care Testing, and Others. The standalone laboratories have dominated the market share of the in-vitro diagnostic global market. It is mainly due to rising testing for new drugs, emerging viruses, and infectious diseases. Moreover, POCT will bolster its market demand in the future, owing to flexible and cost-effective medical devices that help in the diagnosis of conditions within a few minutes. Therefore, the market share of the global in-vitro diagnostics will fuel due to POCT rising demand.
Region Overview in the Global In-vitro Diagnostics Market
Based on geography, the global In-Vitro Diagnostics market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. The North America region will be expecting to witness the highest growth during the forecast period from 2020-2027. It is Owing to rising disposable income, emerging technological advancement, adoption of non-invasive devices, and healthcare facilities.
Global In-vitro Diagnostics Market: Competitive Landscape
Companies such as Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd., Johnson & Johnson, QIAGEN N.V., Sysmex Corporation, and Thermo Fisher Scientific, Inc. and others are key players in the global In-Vitro Diagnostics market.
Global In-Vitro Diagnostics Market Report Content 1. Research Strategic Development 1.1. Market Modelling 1.2. Product Analysis 1.3. Market Trend and Economic Factors Analysis 1.4. Market Segmental Analysis 1.5. Geographical Mapping 1.6. Country Wise Segregation 2. Research Methodology 2.1. Identification of Target Market 2.2. Data Acquisition 2.3. Refining of Data/ Data Transformations 2.4. Data Validation through Primary Techniques 2.5. Exploratory Data Analysis 2.6. Graphical Techniques/Analysis 2.7. Quantitative Techniques/Analysis 2.8. Visual Result/Presentation 3. Executive Summary 4. Market Insights 4.1. Economic Factor Analysis 4.1.1. Drivers 4.1.2. Trends 4.1.3. Opportunities 4.1.4. Challenges 4.2. Competitors & Product Analysis 4.3. Regulatory Framework 4.4. Company market share analysis, 2019 4.5. Porter's Five forces analysis 4.6. New Investment Analysis 4.7. PESTEL Analysis 5. Global In-Vitro Diagnostics Market Overview 5.1. Market Size & Forecast, 2016-2027 5.1.1. Demand 5.1.1.1. By Value (USD Million) 5.2. Market Share & Forecast, 2016-2027 5.2.1. By Product Type 5.2.1.1. Reagents 5.2.1.2. Instruments 5.2.1.3. Software & Services 5.2.2. By Technique 5.2.2.1. Immunodiagnostics 5.2.2.1.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 5.2.2.1.1.2. Chemiluminescence Immunoassays (CLIAS) 5.2.2.1.1.3. Fluorescence Immunoassays (FIAS) 5.2.2.1.1.4. Colorimetric Immunoassays (CIS) 5.2.2.2. Rapid Tests 5.2.2.3. Enzyme-Linked ImmunoSpot Assays (ELISPOT) 5.2.2.4. Radioimmunoassay 5.2.2.5. Western Blot 5.2.2.6. Hematology 5.2.2.7. Molecular Diagnostics 5.2.2.7.1.1. Polymerase Chain Reaction (PCR) 5.2.2.7.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 5.2.2.7.1.3. Hybridization 5.2.2.7.1.4. DNA Diagnostics 5.2.2.7.1.5. Microarrays 5.2.2.7.1.6. Others 5.2.2.8. Tissue Diagnostics 5.2.2.9. Clinical Chemistry 5.2.2.9.1.1. Basic Metabolic Panel 5.2.2.9.1.2. Liver Panel 5.2.2.9.1.3. Lipid Profile 5.2.2.9.1.4. Thyroid Function Panel 5.2.2.9.1.5. Renal Profile 5.2.2.9.1.6. Electrolyte Panel 5.2.2.9.1.7. Specialty Chemicals 5.2.2.10. Other IVD Techniques 5.2.3. By Application 5.2.3.1. Infectious Diseases 5.2.3.2. Cancer 5.2.3.3. Cardiac Diseases 5.2.3.4. Immune System Disorders 5.2.3.5. Nephrological Diseases 5.2.3.6. Gastrointestinal Diseases 5.2.3.7. Other Indications 5.2.4. By End-user 5.2.4.1. Standalone Laboratory 5.2.4.2. Hospitals 5.2.4.3. Academic & Medical Schools 5.2.4.4. Point of Care Testing 5.2.4.5. Others 5.2.5. By Region 5.2.5.1. Europe 5.2.5.2. North America 5.2.5.3. Asia Pacific 5.2.5.4. South America 5.2.5.5. Middle East & Africa 6. Europe In-Vitro Diagnostics Market Overview 6.1. Europe In-Vitro Diagnostics Size & Forecast, 2016-2027 6.1.1. Demand 6.1.1.1. By Value (USD Million) 6.2. Europe In-Vitro Diagnostics Market Share & Forecast, 2016-2027 6.2.1. By Product Type 6.2.1.1. Reagents 6.2.1.2. Instruments 6.2.1.3. Software & Services 6.2.2. By Technique 6.2.2.1. Immunodiagnostics 6.2.2.1.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 6.2.2.1.1.2. Chemiluminescence Immunoassays (CLIAS) 6.2.2.1.1.3. Fluorescence Immunoassays (FIAS) 6.2.2.1.1.4. Colorimetric Immunoassays (CIS) 6.2.2.2. Rapid Tests 6.2.2.3. Enzyme-Linked ImmunoSpot Assays (ELISPOT) 6.2.2.4. Radioimmunoassay 6.2.2.5. Western Blot 6.2.2.6. Hematology 6.2.2.7. Molecular Diagnostics 6.2.2.7.1.1. Polymerase Chain Reaction (PCR) 6.2.2.7.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 6.2.2.7.1.3. Hybridization 6.2.2.7.1.4. DNA Diagnostics 6.2.2.7.1.5. Microarrays 6.2.2.7.1.6. Others 6.2.2.8. Tissue Diagnostics 6.2.2.9. Clinical Chemistry 6.2.2.9.1.1. Basic Metabolic Panel 6.2.2.9.1.2. Liver Panel 6.2.2.9.1.3. Lipid Profile 6.2.2.9.1.4. Thyroid Function Panel 6.2.2.9.1.5. Renal Profile 6.2.2.9.1.6. Electrolyte Panel 6.2.2.9.1.7. Specialty Chemicals 6.2.2.10. Other IVD Techniques 6.2.3. By Application 6.2.3.1. Infectious Diseases 6.2.3.2. Cancer 6.2.3.3. Cardiac Diseases 6.2.3.4. Immune System Disorders 6.2.3.5. Nephrological Diseases 6.2.3.6. Gastrointestinal Diseases 6.2.3.7. Other Indications 6.2.4. By End-user 6.2.4.1. Standalone Laboratory 6.2.4.2. Hospitals 6.2.4.3. Academic & Medical Schools 6.2.4.4. Point of Care Testing 6.2.4.5. Others 6.2.5. By Country 6.2.5.1. Germany 6.2.5.2. UK 6.2.5.3. France 6.2.5.4. Italy 6.2.5.5. Rest of Europe 6.2.6. Company Market Share (Top 3-5) 6.2.7. Economic Impact Study on Europe In-Vitro Diagnostics Market 7. North America In-Vitro Diagnostics Market Overview 7.1. North America In-Vitro Diagnostics Market Size & Forecast, 2016-2027 7.1.1. Demand 7.1.1.1. By Value (USD Million) 7.2. North America In-Vitro Diagnostics Market Share & Forecast, 2016-2027 7.2.1. By Product Type 7.2.1.1. Reagents 7.2.1.2. Instruments 7.2.1.3. Software & Services 7.2.2. By Technique 7.2.2.1. Immunodiagnostics 7.2.2.1.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 7.2.2.1.1.2. Chemiluminescence Immunoassays (CLIAS) 7.2.2.1.1.3. Fluorescence Immunoassays (FIAS) 7.2.2.1.1.4. Colorimetric Immunoassays (CIS) 7.2.2.2. Rapid Tests 7.2.2.3. Enzyme-Linked ImmunoSpot Assays (ELISPOT) 7.2.2.4. Radioimmunoassay 7.2.2.5. Western Blot 7.2.2.6. Hematology 7.2.2.7. Molecular Diagnostics 7.2.2.7.1.1. Polymerase Chain Reaction (PCR) 7.2.2.7.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 7.2.2.7.1.3. Hybridization 7.2.2.7.1.4. DNA Diagnostics 7.2.2.7.1.5. Microarrays 7.2.2.7.1.6. Others 7.2.2.8. Tissue Diagnostics 7.2.2.9. Clinical Chemistry 7.2.2.9.1.1. Basic Metabolic Panel 7.2.2.9.1.2. Liver Panel 7.2.2.9.1.3. Lipid Profile 7.2.2.9.1.4. Thyroid Function Panel 7.2.2.9.1.5. Renal Profile 7.2.2.9.1.6. Electrolyte Panel 7.2.2.9.1.7. Specialty Chemicals 7.2.2.10. Other IVD Techniques 7.2.3. By Application 7.2.3.1. Infectious Diseases 7.2.3.2. Cancer 7.2.3.3. Cardiac Diseases 7.2.3.4. Immune System Disorders 7.2.3.5. Nephrological Diseases 7.2.3.6. Gastrointestinal Diseases 7.2.3.7. Other Indications 7.2.4. By End-user 7.2.4.1. Standalone Laboratory 7.2.4.2. Hospitals 7.2.4.3. Academic & Medical Schools 7.2.4.4. Point of Care Testing 7.2.4.5. Others 7.2.5. By Country 7.2.5.1. US 7.2.5.2. Canada 7.2.5.3. Mexico 7.2.6. Company Market Share (Top 3-5) 7.2.7. Economic Impact Study on North America In-Vitro Diagnostics Market 8. Asia Pacific In-Vitro Diagnostics Overview 8.1. Asia Pacific In-Vitro Diagnostics Market Size & Forecast, 2016-2027 8.1.1. Demand 8.1.1.1. By Value (USD Million) 8.2. Asia Pacific In-Vitro Diagnostics Market Share & Forecast, 2016-2027 8.2.1. By Product Type 8.2.1.1. Reagents 8.2.1.2. Instruments 8.2.1.3. Software & Services 8.2.2. By Technique 8.2.2.1. Immunodiagnostics 8.2.2.1.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 8.2.2.1.1.2. Chemiluminescence Immunoassays (CLIAS) 8.2.2.1.1.3. Fluorescence Immunoassays (FIAS) 8.2.2.1.1.4. Colorimetric Immunoassays (CIS) 8.2.2.2. Rapid Tests 8.2.2.3. Enzyme-Linked ImmunoSpot Assays (ELISPOT) 8.2.2.4. Radioimmunoassay 8.2.2.5. Western Blot 8.2.2.6. Hematology 8.2.2.7. Molecular Diagnostics 8.2.2.7.1.1. Polymerase Chain Reaction (PCR) 8.2.2.7.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 8.2.2.7.1.3. Hybridization 8.2.2.7.1.4. DNA Diagnostics 8.2.2.7.1.5. Microarrays 8.2.2.7.1.6. Others 8.2.2.8. Tissue Diagnostics 8.2.2.9. Clinical Chemistry 8.2.2.9.1.1. Basic Metabolic Panel 8.2.2.9.1.2. Liver Panel 8.2.2.9.1.3. Lipid Profile 8.2.2.9.1.4. Thyroid Function Panel 8.2.2.9.1.5. Renal Profile 8.2.2.9.1.6. Electrolyte Panel 8.2.2.9.1.7. Specialty Chemicals 8.2.2.10. Other IVD Techniques 8.2.3. By Application 8.2.3.1. Infectious Diseases 8.2.3.2. Cancer 8.2.3.3. Cardiac Diseases 8.2.3.4. Immune System Disorders 8.2.3.5. Nephrological Diseases 8.2.3.6. Gastrointestinal Diseases 8.2.3.7. Other Indications 8.2.4. By End-user 8.2.4.1. Standalone Laboratory 8.2.4.2. Hospitals 8.2.4.3. Academic & Medical Schools 8.2.4.4. Point of Care Testing 8.2.4.5. Others 8.2.5. By Country 8.2.5.1. China 8.2.5.2. India 8.2.5.3. Japan 8.2.5.4. Australia 8.2.5.5. Rest of Asia Pacific 8.2.6. Company Market Share (Top 3-5) 8.2.7. Economic Impact Study on Asia Pacific In-Vitro Diagnostics Market 9. South America In-Vitro Diagnostics Market Overview 9.1. South America In-Vitro Diagnostics Market Size & Forecast, 2016-2027 9.1.1. Demand 9.1.1.1. By Value (USD Million) 9.2. South America In-Vitro Diagnostics Market Share & Forecast, 2016-2027 9.2.1. By Product Type 9.2.1.1. Reagents 9.2.1.2. Instruments 9.2.1.3. Software & Services 9.2.2. By Technique 9.2.2.1. Immunodiagnostics 9.2.2.1.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 9.2.2.1.1.2. Chemiluminescence Immunoassays (CLIAS) 9.2.2.1.1.3. Fluorescence Immunoassays (FIAS) 9.2.2.1.1.4. Colorimetric Immunoassays (CIS) 9.2.2.2. Rapid Tests 9.2.2.3. Enzyme-Linked ImmunoSpot Assays (ELISPOT) 9.2.2.4. Radioimmunoassay 9.2.2.5. Western Blot 9.2.2.6. Hematology 9.2.2.7. Molecular Diagnostics 9.2.2.7.1.1. Polymerase Chain Reaction (PCR) 9.2.2.7.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 9.2.2.7.1.3. Hybridization 9.2.2.7.1.4. DNA Diagnostics 9.2.2.7.1.5. Microarrays 9.2.2.7.1.6. Others 9.2.2.8. Tissue Diagnostics 9.2.2.9. Clinical Chemistry 9.2.2.9.1.1. Basic Metabolic Panel 9.2.2.9.1.2. Liver Panel 9.2.2.9.1.3. Lipid Profile 9.2.2.9.1.4. Thyroid Function Panel 9.2.2.9.1.5. Renal Profile 9.2.2.9.1.6. Electrolyte Panel 9.2.2.9.1.7. Specialty Chemicals 9.2.2.10. Other IVD Techniques 9.2.3. By Application 9.2.3.1. Infectious Diseases 9.2.3.2. Cancer 9.2.3.3. Cardiac Diseases 9.2.3.4. Immune System Disorders 9.2.3.5. Nephrological Diseases 9.2.3.6. Gastrointestinal Diseases 9.2.3.7. Other Indications 9.2.4. By End-user 9.2.4.1. Standalone Laboratory 9.2.4.2. Hospitals 9.2.4.3. Academic & Medical Schools 9.2.4.4. Point of Care Testing 9.2.4.5. Others 9.2.5. By Country 9.2.5.1. Brazil 9.2.5.2. Argentina 9.2.5.3. Rest of South America 9.2.6. Company Market Share (Top 3-5) 9.2.7. Economic Impact Study on South America In-Vitro Diagnostics Market 10. Middle East & Africa In-Vitro Diagnostics Market Overview 10.1. Middle East & Africa In-Vitro Diagnostics Market Size & Forecast, 2016-2027 10.1.1. Demand 10.1.1.1. By Value (USD Million) 10.2. Middle East & Africa In-Vitro Diagnostics Market Share & Forecast, 2016-2027 10.2.1. By Product Type 10.2.1.1. Reagents 10.2.1.2. Instruments 10.2.1.3. Software & Services 10.2.2. By Technique 10.2.2.1. Immunodiagnostics 10.2.2.1.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 10.2.2.1.1.2. Chemiluminescence Immunoassays (CLIAS) 10.2.2.1.1.3. Fluorescence Immunoassays (FIAS) 10.2.2.1.1.4. Colorimetric Immunoassays (CIS) 10.2.2.2. Rapid Tests 10.2.2.3. Enzyme-Linked ImmunoSpot Assays (ELISPOT) 10.2.2.4. Radioimmunoassay 10.2.2.5. Western Blot 10.2.2.6. Hematology 10.2.2.7. Molecular Diagnostics 10.2.2.7.1.1. Polymerase Chain Reaction (PCR) 10.2.2.7.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 10.2.2.7.1.3. Hybridization 10.2.2.7.1.4. DNA Diagnostics 10.2.2.7.1.5. Microarrays 10.2.2.7.1.6. Others 10.2.2.8. Tissue Diagnostics 10.2.2.9. Clinical Chemistry 10.2.2.9.1.1. Basic Metabolic Panel 10.2.2.9.1.2. Liver Panel 10.2.2.9.1.3. Lipid Profile 10.2.2.9.1.4. Thyroid Function Panel 10.2.2.9.1.5. Renal Profile 10.2.2.9.1.6. Electrolyte Panel 10.2.2.9.1.7. Specialty Chemicals 10.2.2.10. Other IVD Techniques 10.2.3. By Application 10.2.3.1. Infectious Diseases 10.2.3.2. Cancer 10.2.3.3. Cardiac Diseases 10.2.3.4. Immune System Disorders 10.2.3.5. Nephrological Diseases 10.2.3.6. Gastrointestinal Diseases 10.2.3.7. Other Indications 10.2.4. By End-user 10.2.4.1. Standalone Laboratory 10.2.4.2. Hospitals 10.2.4.3. Academic & Medical Schools 10.2.4.4. Point of Care Testing 10.2.4.5. Others 10.2.5. By Country 10.2.5.1. Saudi Arabia 10.2.5.2. UAE 10.2.5.3. South Africa 10.2.5.4. Rest of Middle East & Africa 10.2.6. Company Market Share (Top 3-5) 10.2.7. Economic Impact Study on Middle East & Africa In-Vitro Diagnostics Market 11. Competitor Analysis 11.1. Company Description 11.2. Financial Analysis 11.3. Key Products 11.4. Key Management Personnel 11.5. Contact Address 11.6. SWOT Analysis 11.7. Company Profile 11.7.1.1. Abbott Laboratories 11.7.1.2. Becton, Dickinson and Company 11.7.1.3. bioMérieux SA 11.7.1.4. Bio-Rad Laboratories, Inc. 11.7.1.5. Danaher Corporation (Beckman Coulter, Inc.) 11.7.1.6. F. Hoffmann-La Roche Ltd. 11.7.1.7. Johnson & Johnson 11.7.1.8. QIAGEN N.V. 11.7.1.9. Sysmex Corporation 11.7.1.10. Thermo Fisher Scientific, Inc 11.7.1.11. Other players
| Price : US$ 3450 | Date : Oct 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 191 |
| Price : US$ 3450 | Date : Oct 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 196 |
| Price : US$ 3450 | Date : Oct 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 194 |
| Price : US$ 3750 | Date : Oct 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 205 |
| Price : US$ 3500 | Date : Oct 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 162 |
We will be happy to help you find what you need. Please call us or write to us:
Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).
This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection
Request Sample 
Request Discount 
Inquire Before Buy
